Selected research
Industry Research
Artemether Industry Research Report 2026
Market perspective
The global Artemether market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Artemether is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Artemether is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Artemether is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Artemether include Ankang ChiaTai Pharmaceutical, Guangzhou Hanfang Pharmaceutical, Shreeji Pharma International, KPC Pharmaceuticals and HOFON, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Artemether market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Artemether Market by Company
Ankang ChiaTai Pharmaceutical
Guangzhou Hanfang Pharmaceutical
Shreeji Pharma International
KPC Pharmaceuticals
HOFON
Artemether Segment by Type
Capsules Artemether
Tablets Artemether
Injectables Artemether
Artemether Segment by Application
Clinic
Hospital
Laboratory
Others
Artemether Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artemether market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artemether and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artemether.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Artemether manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Artemether by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Artemether in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsules Artemether
- Tablets Artemether
- Injectables Artemether
Applications
- Clinic
- Hospital
- Laboratory
- Others
Companies covered
- Ankang ChiaTai Pharmaceutical
- Guangzhou Hanfang Pharmaceutical
- Shreeji Pharma International
- KPC Pharmaceuticals
- HOFON
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Artemether Market Size (2021-2032)
- 2.2.2 Global Artemether Sales (2021-2032)
- 2.2.3 Global Artemether Market Average Price (2021-2032)
- 2.3 Artemether by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Capsules Artemether
- 2.3.3 Tablets Artemether
- 2.3.4 Injectables Artemether
- 2.4 Artemether by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinic
- 2.4.3 Hospital
- 2.4.4 Laboratory
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Artemether Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Artemether Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Artemether Revenue of Manufacturers (2021-2026)
- 3.4 Global Artemether Average Price by Manufacturers (2021-2026)
- 3.5 Global Artemether Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Artemether, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Artemether, Product Type & Application
- 3.8 Global Manufacturers of Artemether, Established Date
- 3.9 Global Artemether Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Ankang ChiaTai Pharmaceutical
- 4.1.1 Ankang ChiaTai Pharmaceutical Company Information
- 4.1.2 Ankang ChiaTai Pharmaceutical Business Overview
- 4.1.3 Ankang ChiaTai Pharmaceutical Artemether Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Ankang ChiaTai Pharmaceutical Artemether Product Portfolio
- 4.1.5 Ankang ChiaTai Pharmaceutical Recent Developments
- 4.2 Guangzhou Hanfang Pharmaceutical
- 4.2.1 Guangzhou Hanfang Pharmaceutical Company Information
- 4.2.2 Guangzhou Hanfang Pharmaceutical Business Overview
- 4.2.3 Guangzhou Hanfang Pharmaceutical Artemether Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Guangzhou Hanfang Pharmaceutical Artemether Product Portfolio
- 4.2.5 Guangzhou Hanfang Pharmaceutical Recent Developments
- 4.3 Shreeji Pharma International
- 4.3.1 Shreeji Pharma International Company Information
- 4.3.2 Shreeji Pharma International Business Overview
- 4.3.3 Shreeji Pharma International Artemether Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shreeji Pharma International Artemether Product Portfolio
- 4.3.5 Shreeji Pharma International Recent Developments
- 4.4 KPC Pharmaceuticals
- 4.4.1 KPC Pharmaceuticals Company Information
- 4.4.2 KPC Pharmaceuticals Business Overview
- 4.4.3 KPC Pharmaceuticals Artemether Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 KPC Pharmaceuticals Artemether Product Portfolio
- 4.4.5 KPC Pharmaceuticals Recent Developments
- 4.5 HOFON
- 4.5.1 HOFON Company Information
- 4.5.2 HOFON Business Overview
- 4.5.3 HOFON Artemether Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 HOFON Artemether Product Portfolio
- 4.5.5 HOFON Recent Developments
5 Global Artemether Market Scenario by Region
- 5.1 Global Artemether Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Artemether Sales by Region: 2021-2032
- 5.2.1 Global Artemether Sales by Region: 2021-2026
- 5.2.2 Global Artemether Sales by Region: 2027-2032
- 5.3 Global Artemether Revenue by Region: 2021-2032
- 5.3.1 Global Artemether Revenue by Region: 2021-2026
- 5.3.2 Global Artemether Revenue by Region: 2027-2032
- 5.4 North America Artemether Market Facts & Figures by Country
- 5.4.1 North America Artemether Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Artemether Sales by Country (2021-2032)
- 5.4.3 North America Artemether Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Artemether Market Facts & Figures by Country
- 5.5.1 Europe Artemether Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Artemether Sales by Country (2021-2032)
- 5.5.3 Europe Artemether Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Artemether Market Facts & Figures by Country
- 5.6.1 Asia Pacific Artemether Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Artemether Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Artemether Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Artemether Market Facts & Figures by Country
- 5.7.1 South America Artemether Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Artemether Sales by Country (2021-2032)
- 5.7.3 South America Artemether Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Artemether Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Artemether Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Artemether Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Artemether Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Artemether Sales by Type (2021-2032)
- 6.1.1 Global Artemether Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Artemether Sales Market Share by Type (2021-2032)
- 6.2 Global Artemether Revenue by Type (2021-2032)
- 6.2.1 Global Artemether Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Artemether Revenue Market Share by Type (2021-2032)
- 6.3 Global Artemether Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Artemether Sales by Application (2021-2032)
- 7.1.1 Global Artemether Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Artemether Sales Market Share by Application (2021-2032)
- 7.2 Global Artemether Revenue by Application (2021-2032)
- 7.2.1 Global Artemether Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Artemether Revenue Market Share by Application (2021-2032)
- 7.3 Global Artemether Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Artemether Value Chain Analysis
- 8.1.1 Artemether Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Artemether Production Mode & Process
- 8.2 Artemether Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Artemether Distributors
- 8.2.3 Artemether Customers
9 Global Artemether Analyzing Market Dynamics
- 9.1 Artemether Industry Trends
- 9.2 Artemether Industry Drivers
- 9.3 Artemether Industry Opportunities and Challenges
- 9.4 Artemether Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst